• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

德国心血管疾病风险预防与管理的障碍——EURIKA研究分析

Barriers to cardiovascular risk prevention and management in Germany--an analysis of the EURIKA study.

作者信息

Schmieder Roland E, Goebel Matthias, Bramlage Peter

机构信息

Nephrology and Hypertension, University Hospital Erlangen, Germany.

出版信息

Vasc Health Risk Manag. 2012;8:177-86. doi: 10.2147/VHRM.S29915. Epub 2012 Mar 15.

DOI:10.2147/VHRM.S29915
PMID:22536072
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3333468/
Abstract

BACKGROUND AND PURPOSE

Despite the availability of risk engines to determine cardiovascular risk, risk factor control is suboptimal. Using EURIKA data we compared risk factor control in Germany with that of 11 other European countries (rest of Europe [ROE]) to identify differences and opportunities for improvement.

METHODS

EURIKA was a multinational, cross-sectional study in 12 European countries including Germany from May 2009 to January 2010. Physicians' attitudes to risk factor control based on the 2007 European guidelines on cardiovascular disease (CVD) prevention in a representative cohort of 7641 primary care outpatients aged ≥ 50 years with no CV disease and at least one major CV risk factor were determined.

RESULTS

Compared to the ROE, German physicians were more frequently male (72.7% vs 62.6%), had a higher mean age (51.7 ± 8.4 vs 47.0 ± 9.7 years), faced higher patient loads (37.9% vs 16.5% had >199 patients/week), and involved other health sector professionals (dieticians, psychologists) less (31.8% vs 41.0% in the ROE). The European Society of Cardiology (ESC) guidelines on CVD prevention were more important for German physicians (60.6% vs 55.9%), while those who didn't use them gave reasons for nonuse as too many (62.5% vs 46.2%), too confusing, unrealistic, or not applicable to their patients. Risk engines were used less (54.5% vs 70.7%), with perceived lack of time (65.5% vs 60.2%) a frequent reason for nonuse. Risk factor control in German patients was inadequate (control rates: hypertension 36.3%, dyslipidemia 30.4%, type 2 diabetes 40.6%, obesity 28.8%) but largely comparable to other ROE countries; however, physicians tended to overestimate control rates.

CONCLUSION

EURIKA provides comprehensive data on the status of primary prevention of CVD in clinical practice in Germany and reveals considerable potential for improving the primary prevention of CVD.

摘要

背景与目的

尽管已有风险评估工具来确定心血管疾病风险,但风险因素控制仍未达到最佳状态。我们利用EURIKA研究数据,比较了德国与其他11个欧洲国家(欧洲其他地区[ROE])的风险因素控制情况,以找出差异和改进机会。

方法

EURIKA是一项于2009年5月至2010年1月在包括德国在内的12个欧洲国家开展的跨国横断面研究。在一个具有代表性的队列中,对7641名年龄≥50岁、无心血管疾病且至少有一项主要心血管风险因素的初级保健门诊患者,根据2007年欧洲心血管疾病(CVD)预防指南,确定医生对风险因素控制的态度。

结果

与欧洲其他地区相比,德国医生男性比例更高(72.7%对62.6%),平均年龄更大(51.7±8.4岁对47.0±9.7岁),患者负担更重(37.9%对16.5%的医生每周接诊患者>199例),且较少与其他卫生部门专业人员(营养师、心理学家)合作(欧洲其他地区为41.0%,德国为31.8%)。欧洲心脏病学会(ESC)的CVD预防指南对德国医生更为重要(60.6%对55.9%),而未使用该指南的医生给出的未使用原因是指南内容过多(62.5%对46.2%)、过于复杂、不切实际或不适用于他们的患者。风险评估工具的使用率较低(54.5%对70.7%),认为缺乏时间(65.5%对60.2%)是未使用的常见原因。德国患者的风险因素控制情况不佳(控制率:高血压36.3%,血脂异常30.4%,2型糖尿病4,0.6%,肥胖28.8%),但在很大程度上与欧洲其他地区国家相当;然而,医生往往高估了控制率。

结论

EURIKA提供了德国临床实践中心血管疾病一级预防状况的全面数据,并揭示了改善心血管疾病一级预防的巨大潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f475/3333468/cb38df91bbd8/vhrm-8-177f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f475/3333468/7e62300bbdb5/vhrm-8-177f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f475/3333468/0beb77a63a49/vhrm-8-177f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f475/3333468/cb38df91bbd8/vhrm-8-177f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f475/3333468/7e62300bbdb5/vhrm-8-177f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f475/3333468/0beb77a63a49/vhrm-8-177f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f475/3333468/cb38df91bbd8/vhrm-8-177f3.jpg

相似文献

1
Barriers to cardiovascular risk prevention and management in Germany--an analysis of the EURIKA study.德国心血管疾病风险预防与管理的障碍——EURIKA研究分析
Vasc Health Risk Manag. 2012;8:177-86. doi: 10.2147/VHRM.S29915. Epub 2012 Mar 15.
2
Survey of physicians' practices in the control of cardiovascular risk factors: the EURIKA study.医生控制心血管风险因素的实践调查:EURIKA 研究。
Eur J Prev Cardiol. 2012 Jun;19(3):541-50. doi: 10.1177/1741826711407705. Epub 2011 Apr 18.
3
Rationale and methods of the European Study on Cardiovascular Risk Prevention and Management in Daily Practice (EURIKA).EURIKA 研究:欧洲日常实践中心血管风险预防与管理的原理和方法。
BMC Public Health. 2010 Jun 30;10:382. doi: 10.1186/1471-2458-10-382.
4
Primary prevention of cardiovascular disease in Greece: Greek results of the EURIKA study.希腊心血管疾病一级预防:EURIKA 研究的希腊结果。
Hellenic J Cardiol. 2014 May-Jun;55(3):217-26.
5
Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study.欧洲心血管疾病一级预防中致动脉粥样硬化性血脂异常的患病率及治疗情况:EURIKA横断面观察性研究
BMC Cardiovasc Disord. 2017 Jun 17;17(1):160. doi: 10.1186/s12872-017-0591-5.
6
Implementation of Spanish adaptation of the European guidelines on cardiovascular disease prevention in primary care.在基层医疗中实施西班牙版欧洲心血管疾病预防指南。
BMC Fam Pract. 2013 Mar 18;14:36. doi: 10.1186/1471-2296-14-36.
7
Quality of cardiovascular disease care in Ontario, Canada: missed opportunities for prevention - a cross sectional study.加拿大安大略省心血管疾病护理质量:预防机会错失 - 一项横断面研究。
BMC Cardiovasc Disord. 2012 Sep 12;12:74. doi: 10.1186/1471-2261-12-74.
8
Management of cardiovascular risk factors for primary prevention: evaluation of Turkey results of the EURIKA study.原发性预防中心血管危险因素的管理:欧洲心血管疾病预防研究(EURIKA)土耳其研究结果评估
Turk Kardiyol Dern Ars. 2012 Mar;40(2):135-42. doi: 10.5543/tkda.2012.01827.
9
Excess risk attributable to traditional cardiovascular risk factors in clinical practice settings across Europe - The EURIKA Study.欧洲临床实践环境中传统心血管危险因素的超额风险 - EURIKA 研究。
BMC Public Health. 2011 Sep 18;11:704. doi: 10.1186/1471-2458-11-704.
10
Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey.五个欧洲国家基层医疗医生对冠心病预防指南建议的接受情况及感知到的实施情况:重新评估欧洲对心血管治疗的态度(REACT)调查
Fam Pract. 2002 Dec;19(6):596-604. doi: 10.1093/fampra/19.6.596.

引用本文的文献

1
Intradermal Advanced Glycation End-products Relate to Reduced Sciatic Nerve Structural Integrity in Type 2 Diabetes.皮内晚期糖基化终产物与2型糖尿病患者坐骨神经结构完整性降低有关。
Clin Neuroradiol. 2025 Jan 29. doi: 10.1007/s00062-024-01493-1.
2
Barriers and facilitators of adherence to clinical practice guidelines in Germany-A systematic review.德国临床实践指南依从性的障碍与促进因素——一项系统综述
J Eval Clin Pract. 2025 Apr;31(3):e14173. doi: 10.1111/jep.14173. Epub 2024 Oct 16.
3
No association between genetic markers and hypertension control in multiple cross-sectional studies.

本文引用的文献

1
Achievement of lipoprotein goals among patients with metabolic syndrome at high cardiovascular risk across Europe. The EURIKA study.在欧洲,具有高心血管风险的代谢综合征患者的脂蛋白目标达成情况。EURIKA 研究。
Int J Cardiol. 2013 Jun 5;166(1):210-4. doi: 10.1016/j.ijcard.2011.10.094. Epub 2011 Nov 5.
2
Excess risk attributable to traditional cardiovascular risk factors in clinical practice settings across Europe - The EURIKA Study.欧洲临床实践环境中传统心血管危险因素的超额风险 - EURIKA 研究。
BMC Public Health. 2011 Sep 18;11:704. doi: 10.1186/1471-2458-11-704.
3
Survey of physicians' practices in the control of cardiovascular risk factors: the EURIKA study.
在多个横断面研究中,遗传标记与高血压控制之间没有关联。
Sci Rep. 2023 Jul 21;13(1):11811. doi: 10.1038/s41598-023-39103-8.
4
Factors influencing the implementation of cardiovascular risk scoring in primary care: a mixed-method systematic review.影响基层医疗中心血管风险评分实施的因素:一项混合方法的系统评价。
Implement Sci. 2020 Jul 20;15(1):57. doi: 10.1186/s13012-020-01022-x.
5
General practitioners' perspectives on the prevention of cardiovascular disease: systematic review and thematic synthesis of qualitative studies.全科医生对心血管疾病预防的看法:定性研究的系统评价和主题综合。
BMJ Open. 2018 Nov 1;8(11):e021137. doi: 10.1136/bmjopen-2017-021137.
6
Risk factors control for primary prevention of cardiovascular disease in men: Evidence from the Aragon Workers Health Study (AWHS).男性心血管疾病一级预防的危险因素控制:来自阿拉贡工人健康研究(AWHS)的证据。
PLoS One. 2018 Feb 23;13(2):e0193541. doi: 10.1371/journal.pone.0193541. eCollection 2018.
7
Control of cardiovascular risk factors and its determinants in the general population- findings from the STAAB cohort study.一般人群心血管危险因素及其决定因素的控制——STAAB队列研究结果
BMC Cardiovasc Disord. 2017 Nov 2;17(1):276. doi: 10.1186/s12872-017-0708-x.
8
Impact of Clinical Factors on the Achievement of Target Blood Pressure in Hypertensive Patients from Ivanovo Region of Russia: Data of 2015.临床因素对俄罗斯伊万诺沃地区高血压患者血压达标情况的影响:2015年数据
High Blood Press Cardiovasc Prev. 2017 Dec;24(4):425-435. doi: 10.1007/s40292-017-0227-y. Epub 2017 Aug 30.
9
Risk prediction models for colorectal cancer in people with symptoms: a systematic review.有症状人群结直肠癌风险预测模型的系统评价
BMC Gastroenterol. 2016 Jun 13;16(1):63. doi: 10.1186/s12876-016-0475-7.
10
Global Cardiovascular Risk Assessment by Family Physicians in Suez Canal University-Family Medicine Centers-Egypt.埃及苏伊士运河大学家庭医学中心的家庭医生进行的全球心血管风险评估。
J Family Med Prim Care. 2013 Oct-Dec;2(4):365-70. doi: 10.4103/2249-4863.123919.
医生控制心血管风险因素的实践调查:EURIKA 研究。
Eur J Prev Cardiol. 2012 Jun;19(3):541-50. doi: 10.1177/1741826711407705. Epub 2011 Apr 18.
4
Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study.在欧洲的临床实践中实现心血管疾病一级预防的治疗目标:EURIKA 研究。
Eur Heart J. 2011 Sep;32(17):2143-52. doi: 10.1093/eurheartj/ehr080. Epub 2011 Apr 6.
5
Medical care of type 2 diabetes in German disease management programmes: a population-based evaluation.德国疾病管理计划中的 2 型糖尿病医疗护理:基于人群的评估。
Diabetes Metab Res Rev. 2011 May;27(4):383-91. doi: 10.1002/dmrr.1186.
6
Reorientation to more health promotion in health services - a study of barriers and possibilities from the perspective of health professionals.重新将重点转向卫生服务中的更多健康促进——从卫生专业人员的角度研究障碍和可能性。
J Multidiscip Healthc. 2010 Nov 26;3:213-24. doi: 10.2147/JMDH.S14900.
7
General practitioners' views and experiences of over-the-counter simvastatin in Scotland.苏格兰全科医生对非处方辛伐他汀的看法和经验。
Br J Clin Pharmacol. 2010 Sep;70(3):356-9. doi: 10.1111/j.1365-2125.2010.03701.x.
8
Rationale and methods of the European Study on Cardiovascular Risk Prevention and Management in Daily Practice (EURIKA).EURIKA 研究:欧洲日常实践中心血管风险预防与管理的原理和方法。
BMC Public Health. 2010 Jun 30;10:382. doi: 10.1186/1471-2458-10-382.
9
Is there a survival benefit within a German primary care-based disease management program?德国基于初级保健的疾病管理项目是否具有生存获益?
Am J Manag Care. 2010 Jan;16(1):49-54.
10
Characteristics, management and attainment of lipid target levels in diabetic and cardiac patients enrolled in Disease Management Program versus those in routine care: LUTZ registry.参加疾病管理项目的糖尿病和心脏病患者与接受常规护理的患者的血脂目标水平特征、管理及达标情况:LUTZ注册研究
BMC Public Health. 2009 Aug 4;9:280. doi: 10.1186/1471-2458-9-280.